Keratitis, also known as corneal ulcer is an inflammation or irritation of the cornea characterized by typical symptoms of red eye, foreign body sensation, pain, sensitivity to light, watery eyes, and blurred vision.  It can be categorized into mild, moderate and severe form. More extensive or severe keratitis involves deeper layers of the cornea, and if a corneal ulcer develops, a scar may be present upon healing. This will affect the vision, if the central portion of the cornea is involved.

 

In severe ulcerative keratitis, the cornea may perforate, which is an extremely serious situation. It is commonly caused by bacterial or fungal invasions following superficial corneal abrasions. The common infectious agents includes; staphylococcus, streptococcus, herpes (both simplex and zoster), adenovirus, rubeola, rubella, mumps, trachoma, infectious mononucleosis, and pneumococcus. Also at fault may be due to Vitamin A deficiency or broad-spectrum antibiotic drug reactions.

 

 

Request for :- Severe Keratitis free sample page

 

Severe Keratitis Epidemiology  

The Severe Keratitis epidemiology division provide insights about historical and current Severe Keratitis patient pool and forecasted trend for every seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the DelveInsight report also provides the diagnosed patient pool and their trends along with assumptions undertaken.  

 

Severe Keratitis Drug Chapters

Drug chapter segment of the Severe Keratitis report encloses the detailed analysis of Severe Keratitis marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs. It also helps to understand the Severe Keratitis clinical trial details, expressive pharmacological action, agreements and collaborations, approval and patent details, advantages and disadvantages of each included drug and the latest news and press releases.

Severe Keratitis Market Outlook

The Severe Keratitis market outlook of the report helps to build the detailed comprehension of the historic, current, and forecasted Severe Keratitis market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand of better technology. 

This segment gives a thorough detail of Severe Keratitis market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on annual cost of therapy, inclusion and exclusion criterias, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated market data are presented with relevant tables and graphs to give a clear view of the market at first sight. 

According to DelveInsight, Severe Keratitis market in 7MM is expected to change in the study period 2017-2030.

Some of the key companies working on Severe Keratitis that are given below-

1. MC2 Therapeutics 

2. ReGenTree

Drugs covered are given below:- 

1. MC2-03

2. RGN-259

 

Table of contents

1. Key Insights

2. Executive Summary of Severe Keratitis

3. Competitive Intelligence Analysis for Severe Keratitis

4. Severe Keratitis: Market Overview at a Glance

4.1. Severe Keratitis Total Market Share (%) Distribution in 2017

4.2. Severe Keratitis Total Market Share (%) Distribution in 2030

5. Severe Keratitis: Disease Background and Overview

6. Patient Journey

7. Severe Keratitis Epidemiology and Patient Population

8. Treatment Algorithm, Current Treatment, and Medical Practices

8.1. Severe Keratitis Treatment and Management

8.2. Severe Keratitis Treatment Algorithm 

9. Unmet Needs

10. Key Endpoints of Severe Keratitis Treatment

11. Marketed Products

12. Emerging Therapies

13. Severe Keratitis: Seven Major Market Analysis

13.1. Key Findings

13.2. Severe Keratitis Market Size in 7MM

13.3. Severe Keratitis Market Size by Therapies in the 7MM

14. Attribute analysis

15. 7MM: Market Outlook

16. Access and Reimbursement Overview of Severe Keratitis

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

20.1. Bibliography

20.2. Report Methodology

21. DelveInsight Capabilities

22. Disclaimer

23. About DelveInsight

Why should you buy this report?

 

• The report will help in developing business strategies by understanding trends shaping and driving the Severe Keratitis market
• To understand the future market competition in the Severe Keratitis market and Insightful review of the key market drivers and barriers
• Organize sales and marketing efforts by identifying the best opportunities for Severe Keratitis in the US, Europe (Germany, Spain, Italy, France, and the United Kingdom) and Japan
• Identification of strong upcoming players in the market will help in devising strategies that will help in getting ahead of competitors
• Organize sales and marketing efforts by identifying the best opportunities for Severe Keratitis market
• To understand the future market competition in the Severe Keratitis market

Related Reports:-

1. Severe Psoriasis – Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

2. Severe Acne Vulgaris or Severe Recalcitrant Nodular Acne – Epidemiology Forecast to 2030